CN113016955A - Freeze-dried staple food for diabetic cats and preparation method thereof - Google Patents
Freeze-dried staple food for diabetic cats and preparation method thereof Download PDFInfo
- Publication number
- CN113016955A CN113016955A CN202110429694.0A CN202110429694A CN113016955A CN 113016955 A CN113016955 A CN 113016955A CN 202110429694 A CN202110429694 A CN 202110429694A CN 113016955 A CN113016955 A CN 113016955A
- Authority
- CN
- China
- Prior art keywords
- staple food
- polysaccharide
- freeze
- vitamin
- diabetic cats
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 57
- 241000282326 Felis catus Species 0.000 title claims abstract description 46
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 51
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 49
- 239000005017 polysaccharide Substances 0.000 claims abstract description 49
- 239000000463 material Substances 0.000 claims abstract description 39
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 21
- 229930003944 flavone Natural products 0.000 claims abstract description 21
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 21
- 235000011949 flavones Nutrition 0.000 claims abstract description 21
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 241000255789 Bombyx mori Species 0.000 claims abstract description 20
- 229960004203 carnitine Drugs 0.000 claims abstract description 19
- 241000229143 Hippophae Species 0.000 claims abstract description 16
- 229920002678 cellulose Polymers 0.000 claims abstract description 16
- 239000001913 cellulose Substances 0.000 claims abstract description 16
- 241001061264 Astragalus Species 0.000 claims abstract description 15
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 15
- 235000006533 astragalus Nutrition 0.000 claims abstract description 15
- 210000004233 talus Anatomy 0.000 claims abstract description 15
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 14
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 14
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 14
- 229960003178 choline chloride Drugs 0.000 claims abstract description 14
- 239000008518 lycium barbarum polysaccharide Substances 0.000 claims abstract description 14
- 229940069978 calcium supplement Drugs 0.000 claims abstract description 8
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 6
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 241000382353 Pupa Species 0.000 claims abstract description 6
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 5
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims abstract 4
- 239000000047 product Substances 0.000 claims description 30
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 22
- 235000013372 meat Nutrition 0.000 claims description 21
- 229940088594 vitamin Drugs 0.000 claims description 21
- 229930003231 vitamin Natural products 0.000 claims description 21
- 235000013343 vitamin Nutrition 0.000 claims description 21
- 239000011782 vitamin Substances 0.000 claims description 21
- 238000007710 freezing Methods 0.000 claims description 14
- 230000008014 freezing Effects 0.000 claims description 14
- 238000004108 freeze drying Methods 0.000 claims description 13
- 241000251468 Actinopterygii Species 0.000 claims description 12
- 235000019688 fish Nutrition 0.000 claims description 12
- 244000144972 livestock Species 0.000 claims description 12
- 210000001835 viscera Anatomy 0.000 claims description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 11
- 241000287828 Gallus gallus Species 0.000 claims description 11
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 11
- 229930003316 Vitamin D Natural products 0.000 claims description 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 11
- 229930003427 Vitamin E Natural products 0.000 claims description 11
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 11
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical group [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 11
- 229960002401 calcium lactate Drugs 0.000 claims description 11
- 239000001527 calcium lactate Substances 0.000 claims description 11
- 235000011086 calcium lactate Nutrition 0.000 claims description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 11
- 235000019155 vitamin A Nutrition 0.000 claims description 11
- 239000011719 vitamin A Substances 0.000 claims description 11
- 235000019166 vitamin D Nutrition 0.000 claims description 11
- 239000011710 vitamin D Substances 0.000 claims description 11
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 11
- 235000019165 vitamin E Nutrition 0.000 claims description 11
- 229940046009 vitamin E Drugs 0.000 claims description 11
- 239000011709 vitamin E Substances 0.000 claims description 11
- 229940045997 vitamin a Drugs 0.000 claims description 11
- 229940046008 vitamin d Drugs 0.000 claims description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 11
- 239000011265 semifinished product Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 241000972773 Aulopiformes Species 0.000 claims description 5
- 235000019750 Crude protein Nutrition 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 235000019515 salmon Nutrition 0.000 claims description 5
- 230000007480 spreading Effects 0.000 claims description 5
- 238000003892 spreading Methods 0.000 claims description 5
- 235000019784 crude fat Nutrition 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 241001106041 Lycium Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 25
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 16
- 239000008103 glucose Substances 0.000 abstract description 16
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 10
- 235000002723 Dioscorea alata Nutrition 0.000 abstract description 9
- 235000005362 Dioscorea floribunda Nutrition 0.000 abstract description 9
- 235000004868 Dioscorea macrostachya Nutrition 0.000 abstract description 9
- 235000005361 Dioscorea nummularia Nutrition 0.000 abstract description 9
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 abstract description 9
- 235000004879 dioscorea Nutrition 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 102000004877 Insulin Human genes 0.000 abstract description 5
- 108090001061 Insulin Proteins 0.000 abstract description 5
- 229940125396 insulin Drugs 0.000 abstract description 5
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract description 4
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract description 4
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract description 4
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 210000000496 pancreas Anatomy 0.000 abstract description 4
- 208000002249 Diabetes Complications Diseases 0.000 abstract description 3
- 206010012655 Diabetic complications Diseases 0.000 abstract description 3
- 206010022489 Insulin Resistance Diseases 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 230000003907 kidney function Effects 0.000 abstract description 3
- 230000003908 liver function Effects 0.000 abstract description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract description 3
- 230000003248 secreting effect Effects 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 18
- 238000012360 testing method Methods 0.000 description 16
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 15
- 235000013330 chicken meat Nutrition 0.000 description 10
- 235000007056 Dioscorea composita Nutrition 0.000 description 7
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 7
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 7
- 201000001421 hyperglycemia Diseases 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000011868 grain product Nutrition 0.000 description 3
- 230000003345 hyperglycaemic effect Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A23K50/42—Dry feed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
Abstract
The invention provides a freeze-dried staple food for diabetic cats, which comprises 90-95kg of main materials, 0.45-0.55kg of auxiliary materials, 0.01-0.1kg of carnitine, 0.5-1kg of calcium supplement, 0.05-0.08kg of choline chloride and the balance of cellulose, wherein the total weight of the main materials is 100 kg; the adjuvants comprise pupa Bombycis, radix astragali polysaccharide, fructus Lycii polysaccharide, fructus Hippophae flavone, and rhizoma Dioscoreae polysaccharide; the mass ratio of the silkworm chrysalis, the astragalus polysaccharide, the lycium barbarum polysaccharide, the seabuckthorn flavone and the yam polysaccharide (350-: (18-22): (10-15): (2-5): (8-12). The carnitine can improve fat metabolism, and the silkworm chrysalis, the astragalus polysaccharide, the lycium barbarum polysaccharide, the hippophae rhamnoides flavone and the Chinese yam polysaccharide have the effects of reducing blood sugar, improving the function of pancreas secreting insulin, improving glucose tolerance, reducing insulin resistance, improving kidney and liver functions and relieving diabetic complications.
Description
Technical Field
The invention relates to a freeze-dried staple food for diabetic cats and a preparation method thereof, belonging to the technical field of pet food.
Background
In recent years, with the improvement of the living standard of residents in China, pets become a part of the life and emotion of more and more urban people, the role played by the pets gradually changes to fill up the emotional and psychological vacancy of main people by meeting the needs of householders, and the trend also has direct influence on the life of the pets. Many pets are deviating from normal trajectories in dietary structure and lifestyle, such as: the pets are excessively raised, raised with high-calorie feed for a long time, seriously lack of daily life exercise amount, sterilization operation and the like, and under the condition, the pets are easily in an overweight or even obese state and are easily suffered from diabetes.
Diabetes is a common endocrine disease, and under normal conditions, beta cells of the pancreas produce insulin, so that body cells can utilize glucose in blood as an energy source; in the absence of insulin, these glucose levels are unavailable to the body cells, resulting in excessive blood glucose levels, which in turn leads to conditions of persistent hyperglycemia and urine glucose in the body, leading to the onset of disease.
In the prior art, a traditional Chinese medicine physiotherapy mode is adopted to treat diabetes of pet cats, but pure traditional Chinese medicine products cannot meet the nutritional requirements of the pet cats, so that a pet cat staple food with comprehensive nutrition and good blood sugar reduction effect is needed.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide the freeze-dried staple food for the diabetic cats.
The second purpose of the invention is to provide a preparation method of the freeze-dried staple food for the diabetic cats.
In order to achieve the first object, the invention is realized by the following technical scheme: a staple food for diabetic cats comprises, by 100kg, 90-95kg of main materials, 0.45-0.55kg of auxiliary materials, 0.01-0.1kg of carnitine, 0.5-1kg of calcium supplement, 0.05-0.08kg of choline chloride and the balance of cellulose.
By adopting the technical scheme, the carnitine component is added, and the carnitine can influence the fat metabolism of the body, so that the consumption and loss speed and proportion of the carnitine are higher than the loss speed of muscles, the tolerance of the body is improved, and the regulation of the blood sugar level of pets is facilitated.
Preferably, the feed also comprises vitamins, and the addition amount of the vitamins is 6000-.
Preferably, the vitamins comprise vitamin A, vitamin D and vitamin E, and the addition ratio of the vitamin A, the vitamin D and the vitamin E is 120:14: 1.
By adopting the technical scheme, the vitamin A, the vitamin D and the vitamin E are added into the whole formula, and the vitamin is a low-molecular organic compound necessary for maintaining the normal physiological function of animals. The vitamin is neither the source of energy of animal body nor the substance composing animal tissue and organ, but it is the necessary participant of animal metabolism, and the vitamin and mineral have synergistic effect, and the addition of vitamin can help mineral absorption.
Preferably, the main materials comprise livestock meat, viscera and fish, and the mass ratio of the chicken meat, the chicken liver and the salmon is (35-40): (25-30): (20-25).
By adopting the technical scheme, the livestock meat, the viscera and the fish mainly provide nutrient substances such as protein, fat, carbohydrate and the like required by animals.
Preferably, the auxiliary materials comprise silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, seabuckthorn flavone and yam polysaccharide.
Preferably, the mass ratio of the silkworm chrysalis, the astragalus polysaccharide, the lycium barbarum polysaccharide, the seabuckthorn flavone and the yam polysaccharide (350-380): (18-22): (10-15): (2-5): (8-12).
By adopting the technical scheme, the added silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, seabuckthorn flavone and Chinese yam polysaccharide have the effects of reducing blood sugar, improving the function of pancreas to secrete insulin, improving glucose tolerance, reducing insulin resistance, improving kidney and liver functions and relieving diabetic complications.
Preferably, the calcium supplement is calcium lactate.
By adopting the technical scheme, the calcium supplement is added to better improve the content of calcium element in the staple food, and the calcium element and the vitamin C have synergistic effect, so that the bone development of animals is facilitated.
In order to achieve the second object, the invention is realized by the following technical scheme: a preparation method of staple food for diabetic cats comprises the following steps:
s1: placing livestock meat, viscera and fish in a pulverizer to pulverize into meat paste, and transferring into a mixer;
s2: sequentially adding silkworm pupa, carnitine, choline chloride and cellulose, and continuously stirring;
s3: continuously adding calcium supplement, vitamins, radix astragali polysaccharide, fructus Lycii polysaccharide, fructus Hippophae flavone and rhizoma Dioscoreae polysaccharide, stirring for 5min to obtain staple food semi-finished product;
s4: spreading the semi-finished product of the staple food grain, freezing for 0.5-2 h, cutting into blocks, and freezing;
s5: freeze-drying the frozen product;
s6: and packaging and sterilizing the freeze-dried product, wherein the specification is 500 g/bag and 1000 g/bag.
By adopting the technical scheme, the main materials are crushed into minced meat, so that chicken, chicken liver and salmon can be better mixed together, and the raw materials can be uniformly mixed when other raw materials are added later.
Preferably, the freezing condition is freezing for 2-5h at-15 ℃ to-40 ℃; the freeze-drying condition is that the vacuum degree is 0.5torr, the drying time is 9-17h, and the temperature is 40-70 ℃.
Preferably, the content of crude protein in the freeze-dried staple food product for diabetic cats is more than or equal to 45 percent, the content of crude fat is more than or equal to 7.5 percent, the content of water is less than or equal to 8 percent, and the content of crude fiber is less than or equal to 12 percent.
By adopting the technology, the staple food grains are processed in a freeze-drying mode, so that the water content in the product can be quickly reduced, and the storage time of the product is prolonged. The freeze-drying process can reduce the loss of nutrients, reduce the loss of heat-sensitive biological preparations and enzyme preparations and improve the utilization rate of protein; and the pet cat feed has high protein content, low fat content and rich cellulose, and is suitable for pet cats suffering from diabetes.
The invention has the beneficial effects that:
(1) the invention adopts a freeze-drying process, reduces the loss of nutrients, reduces the loss of heat-sensitive biological preparations and enzyme preparations, and improves the utilization rate of protein.
(2) The invention is a product with high protein content, low fat content and rich cellulose, and is suitable for pet cats suffering from diabetes.
(3) The carnitine can improve fat metabolism, and the silkworm chrysalis, the astragalus polysaccharide, the lycium barbarum polysaccharide, the hippophae rhamnoides flavone and the Chinese yam polysaccharide have the effects of reducing blood sugar, improving the function of pancreas secreting insulin, improving glucose tolerance, reducing insulin resistance, improving kidney and liver functions and relieving diabetic complications.
Detailed Description
In order to make the technical means, the creation characteristics, the achievement purposes and the effects of the invention easy to understand, the invention is further described with the specific embodiments.
Example 1
A staple food for diabetic cats comprises 90kg of main material, 0.55kg of auxiliary material, 0.1kg of carnitine, 0.5kg of calcium lactate, 0.08kg of choline chloride, 8.77kg of cellulose and 700000IU of vitamin;
wherein the main materials comprise livestock meat, viscera and fish in a mass ratio of 7:5: 4;
the auxiliary materials comprise silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, seabuckthorn flavone and yam polysaccharide in a mass ratio of 350:22:15:5: 12;
the addition ratio of vitamin A, vitamin D and vitamin E is 120:14: 1.
A preparation method of staple food for diabetic cats comprises the following steps:
s1: placing chicken, chicken liver and salmon in a grinder to be ground into meat paste, and then transferring the meat paste to a mixer;
s2: sequentially adding silkworm pupa, carnitine, choline chloride and cellulose, and continuously stirring;
s3: continuously adding calcium lactate, vitamins, radix astragali polysaccharide, fructus Lycii polysaccharide, fructus Hippophae flavone and rhizoma Dioscoreae polysaccharide, stirring for 5min to obtain staple food semi-finished product;
s4: spreading the semi-finished product of the staple food grain, freezing for 2h, cutting into blocks, and freezing for 3h at-15 ℃;
s5: freeze-drying the frozen product, wherein the freeze-drying condition is that the vacuum degree is 0.5torr, the drying time is 17h, and the temperature is 40 ℃;
s6: and packaging and sterilizing the freeze-dried product to obtain the freeze-dried staple food for the diabetic cats, wherein the specifications are 500 g/bag and 1000 g/bag.
Example 2
A staple food for diabetic cats comprises 95kg of main material, 0.45kg of auxiliary material, 0.01kg of carnitine, 1kg of calcium lactate, 0.05kg of choline chloride, 3.49kg of cellulose and 600000IU of vitamin additive;
wherein the main materials comprise livestock meat, viscera and fish in a mass ratio of 8:5: 5;
the auxiliary materials comprise silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, seabuckthorn flavone and yam polysaccharide in a mass ratio of 350:18:15:2: 12;
the addition ratio of vitamin A, vitamin D and vitamin E is 120:14: 1.
A preparation method of staple food for diabetic cats comprises the following steps:
s1: placing chicken, chicken liver and salmon in a grinder to be ground into meat paste, and then transferring the meat paste to a mixer;
s2: sequentially adding silkworm pupa, carnitine, choline chloride and cellulose, and continuously stirring;
s3: continuously adding calcium lactate, vitamins, radix astragali polysaccharide, fructus Lycii polysaccharide, fructus Hippophae flavone and rhizoma Dioscoreae polysaccharide, stirring for 5min to obtain staple food semi-finished product;
s4: spreading the semi-finished product of the staple food grain, freezing for 2h, cutting into blocks, and freezing for 4h at-30 ℃;
s5: freeze-drying the frozen product, wherein the freeze-drying condition is that the vacuum degree is 0.5torr, the drying time is 15h, and the temperature is 50 ℃;
s6: and packaging and sterilizing the freeze-dried product to obtain the diabetic cat staple food product with the specification of 500 g/bag and 1000 g/bag.
Example 3
A staple food for diabetic cats comprises 92kg of main material, 0.5kg of auxiliary material, 0.05kg of carnitine, 0.5kg of calcium lactate, 0.08kg of choline chloride, 6.87kg of cellulose and 650000IU of vitamin;
wherein the main materials comprise livestock meat, viscera and fish in a mass ratio of 7:6: 5;
the auxiliary materials comprise silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, seabuckthorn flavone and yam polysaccharide in a mass ratio of 380:22:10:5: 8;
the addition ratio of vitamin A, vitamin D and vitamin E is 120:14: 1.
A preparation method of staple food for diabetic cats comprises the following steps:
s1: placing livestock meat, viscera and fish in a pulverizer to pulverize into meat paste, and transferring into a mixer;
s2: sequentially adding silkworm pupa, carnitine, choline chloride and cellulose, and continuously stirring;
s3: continuously adding calcium lactate, vitamins, radix astragali polysaccharide, fructus Lycii polysaccharide, fructus Hippophae flavone and rhizoma Dioscoreae polysaccharide, stirring for 5min to obtain staple food semi-finished product;
s4: spreading the semi-finished product of the staple food grain, freezing for 1h, cutting into blocks, and freezing for 3h at-30 ℃;
s5: freeze-drying the frozen product, wherein the freeze-drying condition is that the vacuum degree is 0.5torr, the drying time is 9 hours, and the temperature is 70 ℃;
s6: and packaging and sterilizing the freeze-dried product to obtain the diabetic cat staple food product with the specification of 500 g/bag and 1000 g/bag.
Example 4
A staple food for diabetic cats comprises 90kg of main material, 0.48kg of auxiliary material, 0.08kg of carnitine, 0.7kg of calcium lactate, 0.08kg of choline chloride, 8.66kg of cellulose and 700000IU of vitamin addition;
wherein the main materials comprise livestock meat, viscera and fish in a mass ratio of 8:5: 4;
the auxiliary materials comprise silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, seabuckthorn flavone and yam polysaccharide in a mass ratio of 360:20:13:5: 10;
the addition ratio of vitamin A, vitamin D and vitamin E is 120:14: 1.
A preparation method of staple food for diabetic cats, which is the same as the embodiment 1.
Example 5
A staple food for diabetic cats comprises 95kg of main material, 0.45kg of auxiliary material, 0.02kg of carnitine, 1kg of calcium lactate, 0.05kg of choline chloride, 3.48kg of cellulose and 620000IU of vitamin addition;
wherein the main materials comprise livestock meat, viscera and fish in a mass ratio of 7:6: 4;
the auxiliary materials comprise silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, seabuckthorn flavone and yam polysaccharide in a mass ratio of 370:21:14:3: 9;
the addition ratio of vitamin A, vitamin D and vitamin E is 120:14: 1.
A preparation method of staple food for diabetic cats, which is the same as the embodiment 2.
Example 6
A staple food for diabetic cats comprises 94kg of main material, 0.51kg of auxiliary material, 0.1kg of carnitine, 0.8kg of calcium lactate, 0.06kg of choline chloride, 4.53kg of cellulose and 700000IU of vitamin addition;
wherein the main materials comprise livestock meat, viscera and fish in a mass ratio of 7:5: 5;
the auxiliary materials comprise silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, seabuckthorn flavone and yam polysaccharide in a mass ratio of 370:22:13:3: 11;
the addition ratio of vitamin A, vitamin D and vitamin E is 120:14: 1.
A preparation method of staple food for diabetic cats, which is the same as example 3.
Test example 1
And (3) test groups: examples 1 to 6;
the test method comprises the following steps: the method comprises the following steps of detecting the content of crude protein in a main grain product by GB/T6432-. The specific test results are detailed in table 1.
Table 1 ingredient testing in staple food grain products of examples 1-6
| Crude protein/%) | Crude fat/%) | Water content/%) | Crude fiber/%) | |
| Example 1 | 48 | 9 | 6 | 11.5 |
| Example 2 | 45 | 10 | 5.5 | 12 |
| Example 3 | 50 | 8.5 | 8 | 10.8 |
| Example 4 | 49 | 9.5 | 7.5 | 11.2 |
| Example 5 | 52 | 7.5 | 5 | 10.9 |
| Example 6 | 55 | 8 | 6 | 10.5 |
Referring to table 1, the product of the invention has a crude protein content of not less than 45%, a crude fat content of not less than 7.5%, a moisture content of not more than 8%, and a crude fiber content of not more than 7%; products with low moisture content can extend the shelf life of the product.
Test example 2
Test animals: healthy mice, 25 + -2 g in weight, male, were selected, 10 per group.
A sample to be tested: examples 1 to 6.
The test method comprises the following steps:
(1) principle of
Alloxan is a beta-cytotoxic agent that selectively damages the beta-cells of the islets of langerhans in a variety of animals, causing low insulin secretion resulting in experimental diabetes.
(2) Model making of hyperglycemia
After 24 hours of animal fasting, the animal is given alloxan modeling, after 5-7 days of animal fasting for 3-5 hours, blood sugar is measured, and the blood sugar value is 10-25mmol/L, which is the animal with high blood sugar model success.
(3) Blood sugar reduction test of hyperglycemia model animal
The hyperglycemic model animals were selected and grouped according to fasting blood glucose levels for 3-5h, and 1 model control group and 6 experimental groups (component difference is not more than 1.1mmol/L) were randomly selected. The experimental group was administered with the products of examples 1-6, and the model control group was administered with chicken for 30 consecutive days to measure fasting blood glucose values (fasting as before the experiment). Blood glucose values were compared for each group of animals.
Wherein: experimental group 1 was given the product of example 1, experimental group 2 was given the product of example 2, experimental group 3 was given the product of example 3, and so on.
(4) Data processing
And (4) carrying out a homogeneity test of variance, wherein the homogeneity of variance is carried out, and carrying out variance analysis by using SPSS20.0 statistical software.
And (3) test results:
(1) results of hyperglycemia and hypoglycemic tests
Compared with the control group, the fasting blood glucose of each experimental group is obviously reduced, and the fasting blood glucose index results of 6 experimental groups are positive, which is detailed in table 3.
TABLE 3 results of hyperglycemia and hypoglycemia tests
In conclusion, the diabetic cat staple food prepared by the invention has no adverse effect on fasting blood glucose of normal mice; positive indexes are presented for both fasting blood sugar and blood sugar reduction percentage of a hyperglycemic model mouse, which shows that the product of the invention has a certain blood sugar reducing function.
Test example 3
Test animals: healthy mice, 25 + -2 g in weight, male, were selected, 10 per group.
A sample to be tested: the staple food grain product obtained in the comparative example 1-3 is obtained by replacing the auxiliary materials in the example 1-3 with chicken with the same quality;
the test method comprises the following steps:
the hyperglycemic model animals were selected and grouped according to fasting blood glucose levels for 3-5h, and 3 model control groups and 3 experimental groups (component difference is not more than 1.1mmol/L) were randomly selected. The experimental group was administered with the products of examples 1 to 3, and the model control group was administered with the products of comparative examples 1 to 3, and fasting blood glucose values were measured for 30 consecutive days (before fasting as in the experiment). Blood glucose values were compared for each group of animals.
Wherein: the experimental group 1 was given the product of example 1, the experimental group 2 was given the product of example 2, the experimental group 3 was given the product of example 3, the control group 1 was given the product of comparative example 1, the control group 2 was given the product of comparative example 2, and the control group 3 was given the product of comparative example 3.
And (3) test results: the results of the hyperglycemia-hypoglycemic tests are detailed in table 4.
TABLE 4 results of hyperglycemia and hypoglycemia tests
As can be seen from Table 4, the effect of reducing blood sugar of the pet cat staple food without the addition of the auxiliary materials is obviously lower than that of the pet cat staple food with the addition of the auxiliary materials, and the silkworm chrysalis, astragalus polysaccharide, lycium barbarum polysaccharide, hippophae rhamnoides flavone and Chinese yam polysaccharide which are selected and used in the application are mutually matched to better achieve the effect of reducing blood sugar.
While there have been shown and described what are at present considered the fundamental principles and essential features of the invention and its advantages, it will be apparent to those skilled in the art that the invention is not limited to the details of the foregoing exemplary embodiments, but is capable of other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.
Claims (10)
1. The freeze-dried staple food for the diabetic cats is characterized by comprising 90-95kg of main materials, 0.45-0.55kg of auxiliary materials, 0.01-0.1kg of carnitine, 0.5-1kg of calcium supplement, 0.05-0.08kg of choline chloride and the balance of cellulose by taking 100kg of the freeze-dried staple food.
2. The lyophilized staple food for diabetic cats according to claim 1, further comprising vitamins, wherein the vitamin is added in an amount of 6000-7000IU/kg of the staple food for diabetic cats.
3. The lyophilized staple food for diabetic cats according to claim 2, wherein the vitamins comprise vitamin A, vitamin D and vitamin E, and the ratio of the vitamin A, the vitamin D and the vitamin E added is 120:14: 1.
4. The freeze-dried staple food for the diabetic cats according to claim 1, wherein the main material comprises livestock meat, viscera and fish, and the mass ratio of the livestock meat, the viscera and the fish is (7-8): (5-6): (4-5).
5. The lyophilized staple food for diabetic cats according to claim 1, wherein the auxiliary materials comprise silkworm chrysalis, astragalus polysaccharides, lycium polysaccharides, hippophae rhamnoides flavone, and yam polysaccharides.
6. The freeze-dried staple food for diabetic cats according to claim 5, wherein the mass ratio of the silkworm chrysalis, the astragalus polysaccharide, the lycium barbarum polysaccharide, the seabuckthorn flavone and the yam polysaccharide (350-380): (18-22): (10-15): (2-5): (8-12).
7. The lyophilized staple food for diabetic cats according to claim 1, wherein the calcium supplement is calcium lactate.
8. A method of making the lyophilized staple food for diabetic cats according to any of claims 1-7, comprising the steps of:
s1: placing chicken, chicken liver and salmon in a grinder to be ground into meat paste, and then transferring the meat paste to a mixer;
s2: sequentially adding silkworm pupa, carnitine, choline chloride and cellulose, and continuously stirring;
s3: continuously adding calcium supplement, vitamins, radix astragali polysaccharide, fructus Lycii polysaccharide, fructus Hippophae flavone and rhizoma Dioscoreae polysaccharide, stirring for 5min to obtain staple food semi-finished product;
s4: spreading the semi-finished product of the staple food grain, freezing for 0.5-2 h, cutting into blocks, and freezing;
s5: freeze-drying the frozen product;
s6: and packaging and sterilizing the freeze-dried product to obtain the freeze-dried staple food for the diabetic cats, wherein the specifications are 500 g/bag and 1000 g/bag.
9. The preparation method of the freeze-dried staple food for the diabetic cats according to claim 8, wherein the freezing condition is freezing at-15 ℃ to-40 ℃ for 2-5 h; the freeze-drying condition is that the vacuum degree is 0.5torr, the drying time is 9-17h, and the temperature is 30-70 ℃.
10. The freeze-dried staple food for diabetic cats prepared by the method of claim 9, wherein the freeze-dried staple food for diabetic cats comprises crude protein content of not less than 45%, crude fat content of not less than 7.5%, moisture content of not more than 8%, and crude fiber content of not more than 12%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110429694.0A CN113016955A (en) | 2021-04-21 | 2021-04-21 | Freeze-dried staple food for diabetic cats and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110429694.0A CN113016955A (en) | 2021-04-21 | 2021-04-21 | Freeze-dried staple food for diabetic cats and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113016955A true CN113016955A (en) | 2021-06-25 |
Family
ID=76457200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110429694.0A Pending CN113016955A (en) | 2021-04-21 | 2021-04-21 | Freeze-dried staple food for diabetic cats and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113016955A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107173594A (en) * | 2017-04-17 | 2017-09-19 | 宠爱生活（厦门）科技有限公司 | A kind of auxotype cat food and preparation method thereof |
| CN110037168A (en) * | 2019-05-16 | 2019-07-23 | 天津朗诺宠物食品有限公司 | A kind of freeze-drying pet food and its preparation process |
| CN111758850A (en) * | 2020-08-04 | 2020-10-13 | 辽宁海辰宠物有机食品有限公司 | Low-allergy grain-free puffed staple food for dogs and cats, composite freeze-dried puffed staple food for dogs and cats, and preparation method and application thereof |
-
2021
- 2021-04-21 CN CN202110429694.0A patent/CN113016955A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107173594A (en) * | 2017-04-17 | 2017-09-19 | 宠爱生活（厦门）科技有限公司 | A kind of auxotype cat food and preparation method thereof |
| CN110037168A (en) * | 2019-05-16 | 2019-07-23 | 天津朗诺宠物食品有限公司 | A kind of freeze-drying pet food and its preparation process |
| CN111758850A (en) * | 2020-08-04 | 2020-10-13 | 辽宁海辰宠物有机食品有限公司 | Low-allergy grain-free puffed staple food for dogs and cats, composite freeze-dried puffed staple food for dogs and cats, and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103704478B (en) | Well-fattened ox or sheep middle and late stage supplements material formula | |
| CN110506834A (en) | A method of cattle and sheep feed is produced using microbial fermentation | |
| CN107912637A (en) | A kind of feed addictive for improving laying rate of laying hen and preparation method thereof | |
| CN108338258A (en) | A kind of farrowing sow Synbiotic feed additive and preparation method and application | |
| CN113142398A (en) | Functional feed additive for ruminants and preparation method thereof | |
| CN103947871B (en) | A kind of meat goose mixed feed and preparation method thereof | |
| CN113519725A (en) | Compound feed for groupers and preparation method of compound feed | |
| CN106036000A (en) | Piglet feed and preparation method thereof | |
| CN109329560A (en) | Solve pregnant sow constipation and the feed addictive of production performance and preparation method thereof | |
| CN106107145A (en) | A kind of feedstuff improving meat Canis familiaris L. resistance against diseases and preparation method | |
| CN113016955A (en) | Freeze-dried staple food for diabetic cats and preparation method thereof | |
| CN103238754A (en) | Compound premix for quick delivery and postpartum recovery of sow and preparation process thereof | |
| CN114176170B (en) | Functional feed additive and preparation method and application thereof | |
| CN109924345B (en) | Sea cucumber feed premix prepared from traditional Chinese medicine residues and preparation method thereof | |
| CN101185482A (en) | Green environmental protection deer feed additive and preparation method thereof | |
| CN104757311B (en) | A kind of fish feed additive and preparation method thereof | |
| CN103875991B (en) | A kind of gosling mixed feed and preparation method thereof | |
| CN106962596A (en) | A kind of fodder for snake and preparation method thereof | |
| CN103947870B (en) | A kind ofly prevent and treat mixed feed of foie gras inflammation and preparation method thereof | |
| CN103316273B (en) | Improve animal immunizing power and promote the Chinese medicine composition of growth of animal | |
| CN101156654A (en) | Environmental protection high calcium high protein deer feed additive | |
| CN107873977B (en) | Lamb starter for promoting rumen development and preparation method thereof | |
| CN111387358A (en) | Feed additive for improving growth performance of fattening pigs | |
| WO2008124994A1 (en) | A green environmental protection feed additive for fowls and domestic animals and its preparation method | |
| CN108813119A (en) | A kind of nonpregnant sows Synbiotic feed additive and preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210625 |